SILBERMAN DAVID (Chief Financial Officer) received a stock award from ORAMED PHARMACEUTICALS INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/8/2024ACC: 0001209191-24-001146
Officer· Chief Financial Officer
Since Jul 2021
+136.50K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
136.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+136.50K
Price / share
—
Trade value
—
% of position
59.3%
1/4/2024
230K→366.50K
Total
Net shares
+136.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/4/2024 | A · Award | +136.50K | — | — | 59.3% | 230K | 366.50K |
| Total | +136.50K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported